Xspray Pharma
27.70 SEK
+2.78 %
Less than 1K followers
XSPRAY
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xspray Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||
| EBITDA | -80.9 | -80.2 | -278.5 | -38.1 | -40.0 | -41.3 | -32.0 | -151.3 |
| EBIT | -82.7 | -81.9 | -287.0 | -39.5 | -41.4 | -42.7 | -33.4 | -156.9 |
| EBIT-% | ||||||||
| Profit before taxes | -82.3 | -82.0 | -285.7 | -42.3 | -44.9 | -47.3 | -37.0 | -171.6 |
| Net income | -82.2 | -82.0 | -285.5 | -42.3 | -44.9 | -47.3 | -37.0 | -171.4 |